SHANGHAI, April 20, 2026 /PRNewswire/ -- Immunofoco today announced the presentation of new preclin...
SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancin...
SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company, focused...
* MxV-G is a novel fusogen for lentiviral packaging that achieves higher vector titers and enhanc...
CHICAGO, June 1, 2024 /PRNewswire/ -- On June 1st, 2024, Immunofoco Biotech, a company dedicated to...
- The first EpCAM targeted CAR-T product obtained US/CN IND approval. - Acceptable safety profiles...